Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03985787
Other study ID # 18-1298
Secondary ID 1R21DK115200-01A
Status Completed
Phase N/A
First received
Last updated
Start date October 24, 2018
Est. completion date May 31, 2021

Study information

Verified date September 2021
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study plans to learn more about how resistance training impacts appetite and the brain's response to food. The study will be evaluating how the brain responds to food images as well as how behaviors and hormones change with a 12 week resistance training intervention.


Description:

Aim 1: To determine if RT impacts neuronal function associated with food intake behavior in a manner favoring reduced EI in overweight/obese adults. Hypothesis: Compared to pre, post-RT fMRI measures will demonstrate ↓ neuronal responses to food cues in the insula, prefrontal cortex, and hypothalamus, brain regions implicated in reward, impulsivity, motivation, and regulation of ingestive behaviors. These changes will be associated with ad libitum EI. Aim 2: To determine if RT impacts appetite-related peptides, ratings, and food intake behaviors in a manner favoring reduced EI in overweight/obese adults. Hypothesis: Compared to pre, post-RT measures will show changes in appetite-related peptides, ratings (↓ hunger ↑ satiety), and behaviors (↓food-related cravings & impulsivity, ↑ self-efficacy) consistent with EI reduction. Changes in appetite regulation indices will be associated with changes in relevant brain networks (Aim 1). These changes will also be associated with ↓ ad libitum EI. Exploratory Aim: To determine if RT impacts neuronal function and appetite-related peptides and behaviors in a manner favoring ↓ EI in Non-Compensators (top tertile of fat mass loss) as compared to Compensators (bottom tertile of fat mass loss). Hypothesis: Compared to Compensators, Non-Compensators will show ↓ neuronal responses to food cues and default network, and changes in appetite-related peptides, ratings, and behaviors consistent with ↓ EI.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date May 31, 2021
Est. primary completion date May 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - all ethnic groups - both sexes - age: 18-55 - BMI: 27-40 kg/m2 - weight stable (±5% in last 6 months) - sedentary (<2 hours of planned physical activity/week by self-report, no RT in previous 12-months) Exclusion Criteria: - history of CVD - DM - uncontrolled Hypertension - untreated thyroid disease - renal disease - hepatic disease - other condition affecting weight/metabolism - unable to exercise - smoker - medications affecting weight - EI or EE in past 6 months - weight loss/gain >5% in past 6 months - post-menopausal women (defined as age appropriate women with 6 months or more of amenorrhea) - currently pregnant, lactating, < 6 months post-partum - woman who have undergone oophorectomy - bariatric surgery - major psychiatric disorder - alcohol or substance abuse - depression by history and/or score >21 on CES-D - history of eating disorders and/or score >20 on EATS-26

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Resistance Training
12-weeks of a full body resistance training intervention. Intervention will consist of 4 training sessions per week that are approximately 45-minutes in length. Two days will be upper body training and 2 days lower body

Locations

Country Name City State
United States University of Colorado Denver - Anschutz Medical Campus Aurora Colorado

Sponsors (2)

Lead Sponsor Collaborator
University of Colorado, Denver National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Changes in Free-Living Physical Activity and Sedentary Time Physical Activity and Sedentary Time will be measured via activPAL (PALTechnologies: Glasgow, Scotland) activity monitor. Participants will be instructed to wear the monitor on their right leg for 7 consecutive days at all times except when sleeping or participating in water-based activities (e.g. showering, swimming). The time-stamped "event" data file from the activPAL software will be used to determine time spent sitting/lying, standing and stepping per day. Baseline, 12 Weeks
Other Changes in Muscular Strength Muscular Strength via 10 repetition maximum of chest and leg press on strength training machines, respectively. Baseline, 12 Weeks
Other Change in Body Mass (kg) Via Digital scale Baseline, 12 Weeks
Other Change in Body Composition Assessment of fat mass and lean mass via DXA scan Baseline, 12 Weeks
Other Change in Neuronal Responses to Food Cues in Regions of Interest by Non-Compensator vs. Compensator groups Changes in the insula, prefrontal cortex, and hypothalamus response to salient food cues (pre vs post-RT) as measured by fMRI in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Change in Neuronal Responses to Food Cues in Regions of Interest by Sex Changes in the insula, prefrontal cortex, and hypothalamus response to salient food cues (pre vs post-RT) as measured by fMRI in response to 12-weeks of RT. Baseline, 12 Weeks
Other Change in Whole Brain Response by Non-Compensator vs. Compensator groups Whole brain changes in response to salient food cues (pre vs post RT) as measured by fMRI in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Change in Whole Brain Response by Sex Whole brain changes in response to salient food cues (pre vs post RT) as measured by fMRI in response to 12-weeks of RT. Baseline, 12 Weeks
Other Change in Default Mode Network by Non-Compensator vs. Compensator groups Changes in the DMN resting state activity and large-scale network connectivity (pre vs post RT) as measured by MRI in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Change in Default Mode Network by Sex Changes in the DMN resting state activity and large-scale network connectivity (pre vs post RT) as measured by MRI in response to 12-weeks of RT. Baseline, 12 Weeks
Other Changes in Appetite Ratings by Non-Compensator vs. Compensator groups Changes in measures of appetite (hunger, satiety, and prospective food consumption) area under the curve [AUC] following a standardized test-meal in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Changes in Appetite Ratings by Sex Changes in measures of appetite (hunger, satiety, and prospective food consumption) area under the curve [AUC] following a standardized test-meal in response to 12-weeks of RT. " Baseline, 12 Weeks
Other Changes in Appetite-Related Hormones by Non-Compensator vs. Compensator groups Changes in appetite-related hormones [ghrelin, PYY, and GLP-1] area under the curve [AUC] following a standardized test meal in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Changes in Appetite-Related Hormones by Sex Changes in appetite-related hormones [ghrelin, PYY, and GLP-1] area under the curve [AUC] following a standardized test meal in response to 12-weeks of RT. Baseline, 12 Weeks
Other Change in In Lab Ad Libitum Energy Intake (kcals) by Non-Compensator vs. Compensator groups Change in In lab ad libitum buffet lunch (via weigh and measure methodology) three hours after breakfast test meal at baseline and post-intervention. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Change in In Lab Ad Libitum Energy Intake (kcals) by Sex Change in In lab ad libitum buffet lunch (via weigh and measure methodology) three hours after breakfast test meal at baseline and post-intervention. Baseline, 12 Weeks
Other Change in Free-Living Ad libitum Energy Intake (kcals) by Non-Compensator vs. Compensator groups Change in Three days of free-living ad libitum energy intake (via DHQ food frequency questionnaire) at baseline and post intervention. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Change in Free-Living Ad libitum Energy Intake (kcals) by Sex Change in Three days of free-living ad libitum energy intake (via DHQ food frequency questionnaire) at baseline and post intervention. Baseline, 12 Weeks
Other Changes in Free-Living Physical Activity and Sedentary Time by Non-Compensator vs. Compensator groups Physical Activity and Sedentary Time will be measured via activPAL (PALTechnologies: Glasgow, Scotland) activity monitor. Participants will be instructed to wear the monitor on their right leg for 7 consecutive days at all times except when sleeping or participating in water-based activities (e.g. showering, swimming). The time-stamped "event" data file from the activPAL software will be used to determine time spent sitting/lying, standing and stepping per day. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Changes in Free-Living Physical Activity and Sedentary Time by Sex Physical Activity and Sedentary Time will be measured via activPAL (PALTechnologies: Glasgow, Scotland) activity monitor. Participants will be instructed to wear the monitor on their right leg for 7 consecutive days at all times except when sleeping or participating in water-based activities (e.g. showering, swimming). The time-stamped "event" data file from the activPAL software will be used to determine time spent sitting/lying, standing and stepping per day. Baseline, 12 Weeks
Other Change in Muscular Strength by Non-Compensators vs Compensators Muscular Strength via 10 repetition maximum of chest and leg press on strength training machines, respectively. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Change in Muscular Strength by Sex Muscular Strength via 10 repetition maximum of chest and leg press on strength training machines, respectively. Baseline, 12 Weeks
Other Change in Body Mass by Non-Compensator vs. Compensator groups Via Digital scale. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Change in Body Mass by Sex Via Digital scale. Baseline, 12 Weeks
Other Change in Body Composition by Non-Compensator vs. Compensator groups Assessment of fat mass and lean mass via DXA scan. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions. Baseline, 12 Weeks
Other Change in Body Composition by Sex Assessment of fat mass and lean mass via DXA scan. Baseline, 12 Weeks
Primary Change in Neuronal Responses to Food Cues in Regions of Interest Changes in the insula, prefrontal cortex, and hypothalamus response to salient food cues (pre vs post-RT) as measured by fMRI in response to 12-weeks of RT Baseline, 12 Weeks
Secondary Change in Whole Brain Response Whole brain changes in response to salient food cues (pre vs post RT) as measured by fMRI in response to 12-weeks of RT Baseline, 12 Weeks
Secondary Change in Default Mode Network Changes in the DMN resting state activity and large-scale network connectivity (pre vs post RT) as measured by MRI in response to 12-weeks of RT Baseline, 12 Weeks
Secondary Changes in Appetite Ratings Changes in measures of appetite (hunger, satiety, and prospective food consumption) area under the curve [AUC] following a standardized test-meal in response to 12-weeks of RT. Baseline, 12 Weeks
Secondary Changes in Appetite-Related Hormones Changes in appetite-related hormones [ghrelin, PYY, and GLP-1] area under the curve [AUC] following a standardized test meal in response to 12-weeks of RT. Baseline, 12 Weeks
Secondary Change in In Lab Ad Libitum Energy Intake (kcals) Change in In lab ad libitum buffet lunch (via weigh and measure methodology) three hours after breakfast test meal at baseline and post-intervention Baseline, 12 Weeks
Secondary Change in Free-Living Ad libitum Energy Intake (kcals) Change in Three days of free-living ad libitum energy intake (via DHQ food frequency questionnaire) at baseline and post intervention. Baseline, 12 Weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2